7. SYMPTOM DOMAINS
SEVERITY
Mood
âą Elevated
Hypomania
âą More persistent and
marked than cyclothymia
âą Several days on end
Physical
activity
âą Quantity
âą Speed
Mania
without
psychosis
âą Greater degree of mood
elevation
âą At least one week
Mental
activity
âą Quantity
âą Speed
Mania with âą Congruous or incongruous
âą Severe and sustained
psychosis
increase in activity
8. Elevated mood >=4days
Symptoms (three or more)
Unequivocal change in functioning
Mood and function change observed by others
No marked impairment in social / occupational functioning & no psychosis
Not due to substance misuse or a medical condition
9. Mood elevate at least 1 week
Symptoms (3 or more)
Not Mixed Episode
Severe impairment of functioning or relationships or need
hospitalisation or psychosis
Not due to substances misuse or a medical condition
14. Bipolar
Depression
Lifetime risk
About 1-5%
10-20%
Sex ratio (M:F)
1:1
1:2
Lifetime risk for bipolar
About 10%
About 2%
Lifetime risk for unipolar depression
20-30%
20-30%
Average age of onset
21 yrs (?earlier)
27 yrs
Suicide
15%
10%
First-degree relatives:
15. Factor
Expressed Emotion
Greater predictor of relapse than schizophrenia
Family history
Complex hereditability
Social class
High social class cf. other mood disorders
Life events
Significant with nature & degree
Personality
More maladaptive traits during relapse
Need for reassurance and sensitivity to criticism
Childhood experience
Approx 50% bipolars and leads to more complex cases
Postpartum
Marked increases
Menopause
Deterioration in perimenopause
Social support
Bipolars get less social support
Sleep deprivation
Tends to mania, circadian disturbances
Behavioural activation
Excessive activity leads to mania
29. ïĄ
Children of affected parent(s)
ï§ One parent: 15-30%
ï§ Both parents: 50-75%
ïĄ
Siblings of affected sibling
ï§ One sibling: 15-25%
ï§ MZ concordance 60-70%
ïĄ
Additional genetic loading for
depressive disorder, ADHD, OCD
or Oppositional Defiant Disorder
31. ïĄ
Bipolar I
ï§ DAO, GRM3, GRM4, GRIN2B, IL2
RB, and TUBA8
ïĄ
Overlapping with
schizophrenia
ï§ DPYSL2, DTNBP1, G30/G72, GRI
D1, GRM4, and NOS1
ïĄ
ïĄ
ïĄ
BDNF
Alpha subunit of the voltagedependent calcium channel
Glutamate signalling
pathways
32. ïĄ
Strongest linkage on
chromosomes
10q25, 10p12, 16q24, 16p13, a
nd 16p12
ïĄ
ïĄ
ïĄ
6q25 (suicidal behaviour)
7q21 (panic disorder)
16p12 (psychosis) using
phenotypic subtypes
33. Bipolar
Unipolar
Substance abuse
+++
+
Family history
++++
+
Seasonality
++++
+
Onset before age 25
+++
+
Postpartum onset
+++
+
Psychotic depression <age 35
+++
--
Atypical features
++++
+
Rapid on/off pattern
++
--
Recurrent Major Depressive Episodes
++
+
Antidepressants associated with hypomania / mania
++
--
++++
--
Antidepressant wear-off
++
--
Mixed depression
++
--
Brief episodes of depression
34. Any mental health history
Recurrent depressive disorder
Any alcohol or substance misuse
Repeated relationship problems
Repeated occupational problems
Family history
35. âą Functional mental illnesses
Recurrent
Depression, Anxiety
âą Emotionally unstable / borderline
Personality disorder types
Substance and
alcohol misuse
âą Chronic or intermittent use
Normal human
emotion
âą Chronic stress & psychosocial
problems
36. Anxiety
disorders
Panic disorder
Simple phobia
Alcohol misuse
Personality
disorders
Childhood
bipolar
Cluster B
Conduct
disorder
Substance
misuse
Childhood
mental
health
Borderline
ADHD
Emotionally
unstable
Social phobia
GAD
OCD
Sleep disorders
PTSD
Any substance
misuse
39. ïĄ
Beating Bipolar
ï§ 3: Section 3
ï§ Get CT1s to discuss each question in 2 groups
âȘ What they think
âȘ What they think the patient might thinks
âȘ Consider pros & Cons
ï§ Watch next film of patients (Mark & Jane)
ïĄ
Dr Alison Roberts â on lithium